Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Avricore Health Inc. buy krebskrebs

Start price
€0.012
26.05.20 / 50%
Target price
€0.010
04.11.21
Performance (%)
743.48%
End price
€0.097
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €0.097. With a performance of 743.48% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Avricore Health Inc. 0.000% 0.000% -49.435% -40.728%
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

Comments by krebskrebs for this prediction

In the thread Avricore Health Inc. diskutieren
Prediction Buy
Perf. (%) 743.48%
Target price 0.010
Change
Ends at 04.11.21

Buy mit Kursziel 0,01

In the thread Trading Avricore Health Inc.
Prediction Buy
Perf. (%) 743.48%
Target price 0.010
Change
Ends at 04.11.21

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten